Idiopathic pulmonary fibrosis in patients younger than 50 years

Hassan F. Nadrous, Jeffrey L. Myers, Paul A. Decker, Jay H Ryu

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

OBJECTIVE: To assess clinical, radiological, histopathologic, and prognostic differences in younger patients with idiopathic pulmonary fibrosis (IPF). PATIENTS AND METHODS: This study consisted of patients younger than 50 years with IPF who were seen at the Mayo Clinic in Rochester, Minn, from January 1, 1994, to December 31, 2000. Clinical, radiological, and histopathologic data were abstracted from clinical records. Total lung capacity using plethysmography, vital capacity, diffusing capacity for carbon monoxide using the single-breath method, and alveolar volume using single-breath neon wash-in were measured. RESULTS: Our study population was composed of 16 men and 6 women with a median age of 45 years (range, 28-49 years). Median survival was 2.1 years, with 1- and 2-year survival rates of 68% and 53%, respectively. Of the 22 patients, 2 were current smokers, 14 were former smokers, and 6 had never smoked. Three patients had familial pulmonary fibrosis, 21 had bibasilar inspiratory crackles, and 10 had digital clubbing. Median total lung capacity was 56.2%, vital capacity was 51.0%, diffusing capacity was 45.5%, and alveolar volume was 65.0%. CONCLUSION: Although previous studies have suggested that younger age is a favorable prognostic factor in patients with IPF, we found that younger patients have the same poor prognosis as do older patients with this disorder. We observed no distinguishing differences in the clinical, radiological, and histopathologic features compared with those in older patients in whom the disorder is more common. Lung transplantation should be considered early in the treatment of younger patients with IPF.

Original languageEnglish (US)
Pages (from-to)37-40
Number of pages4
JournalMayo Clinic Proceedings
Volume80
Issue number1
StatePublished - 2005

Fingerprint

Idiopathic Pulmonary Fibrosis
Total Lung Capacity
Vital Capacity
Neon
Plethysmography
Lung Transplantation
Pulmonary Fibrosis
Respiratory Sounds
Carbon Monoxide
Survival Rate
Survival

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Nadrous, H. F., Myers, J. L., Decker, P. A., & Ryu, J. H. (2005). Idiopathic pulmonary fibrosis in patients younger than 50 years. Mayo Clinic Proceedings, 80(1), 37-40.

Idiopathic pulmonary fibrosis in patients younger than 50 years. / Nadrous, Hassan F.; Myers, Jeffrey L.; Decker, Paul A.; Ryu, Jay H.

In: Mayo Clinic Proceedings, Vol. 80, No. 1, 2005, p. 37-40.

Research output: Contribution to journalArticle

Nadrous, HF, Myers, JL, Decker, PA & Ryu, JH 2005, 'Idiopathic pulmonary fibrosis in patients younger than 50 years', Mayo Clinic Proceedings, vol. 80, no. 1, pp. 37-40.
Nadrous, Hassan F. ; Myers, Jeffrey L. ; Decker, Paul A. ; Ryu, Jay H. / Idiopathic pulmonary fibrosis in patients younger than 50 years. In: Mayo Clinic Proceedings. 2005 ; Vol. 80, No. 1. pp. 37-40.
@article{ff0e970dad74454bb8ffc8125107c3cd,
title = "Idiopathic pulmonary fibrosis in patients younger than 50 years",
abstract = "OBJECTIVE: To assess clinical, radiological, histopathologic, and prognostic differences in younger patients with idiopathic pulmonary fibrosis (IPF). PATIENTS AND METHODS: This study consisted of patients younger than 50 years with IPF who were seen at the Mayo Clinic in Rochester, Minn, from January 1, 1994, to December 31, 2000. Clinical, radiological, and histopathologic data were abstracted from clinical records. Total lung capacity using plethysmography, vital capacity, diffusing capacity for carbon monoxide using the single-breath method, and alveolar volume using single-breath neon wash-in were measured. RESULTS: Our study population was composed of 16 men and 6 women with a median age of 45 years (range, 28-49 years). Median survival was 2.1 years, with 1- and 2-year survival rates of 68{\%} and 53{\%}, respectively. Of the 22 patients, 2 were current smokers, 14 were former smokers, and 6 had never smoked. Three patients had familial pulmonary fibrosis, 21 had bibasilar inspiratory crackles, and 10 had digital clubbing. Median total lung capacity was 56.2{\%}, vital capacity was 51.0{\%}, diffusing capacity was 45.5{\%}, and alveolar volume was 65.0{\%}. CONCLUSION: Although previous studies have suggested that younger age is a favorable prognostic factor in patients with IPF, we found that younger patients have the same poor prognosis as do older patients with this disorder. We observed no distinguishing differences in the clinical, radiological, and histopathologic features compared with those in older patients in whom the disorder is more common. Lung transplantation should be considered early in the treatment of younger patients with IPF.",
author = "Nadrous, {Hassan F.} and Myers, {Jeffrey L.} and Decker, {Paul A.} and Ryu, {Jay H}",
year = "2005",
language = "English (US)",
volume = "80",
pages = "37--40",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "1",

}

TY - JOUR

T1 - Idiopathic pulmonary fibrosis in patients younger than 50 years

AU - Nadrous, Hassan F.

AU - Myers, Jeffrey L.

AU - Decker, Paul A.

AU - Ryu, Jay H

PY - 2005

Y1 - 2005

N2 - OBJECTIVE: To assess clinical, radiological, histopathologic, and prognostic differences in younger patients with idiopathic pulmonary fibrosis (IPF). PATIENTS AND METHODS: This study consisted of patients younger than 50 years with IPF who were seen at the Mayo Clinic in Rochester, Minn, from January 1, 1994, to December 31, 2000. Clinical, radiological, and histopathologic data were abstracted from clinical records. Total lung capacity using plethysmography, vital capacity, diffusing capacity for carbon monoxide using the single-breath method, and alveolar volume using single-breath neon wash-in were measured. RESULTS: Our study population was composed of 16 men and 6 women with a median age of 45 years (range, 28-49 years). Median survival was 2.1 years, with 1- and 2-year survival rates of 68% and 53%, respectively. Of the 22 patients, 2 were current smokers, 14 were former smokers, and 6 had never smoked. Three patients had familial pulmonary fibrosis, 21 had bibasilar inspiratory crackles, and 10 had digital clubbing. Median total lung capacity was 56.2%, vital capacity was 51.0%, diffusing capacity was 45.5%, and alveolar volume was 65.0%. CONCLUSION: Although previous studies have suggested that younger age is a favorable prognostic factor in patients with IPF, we found that younger patients have the same poor prognosis as do older patients with this disorder. We observed no distinguishing differences in the clinical, radiological, and histopathologic features compared with those in older patients in whom the disorder is more common. Lung transplantation should be considered early in the treatment of younger patients with IPF.

AB - OBJECTIVE: To assess clinical, radiological, histopathologic, and prognostic differences in younger patients with idiopathic pulmonary fibrosis (IPF). PATIENTS AND METHODS: This study consisted of patients younger than 50 years with IPF who were seen at the Mayo Clinic in Rochester, Minn, from January 1, 1994, to December 31, 2000. Clinical, radiological, and histopathologic data were abstracted from clinical records. Total lung capacity using plethysmography, vital capacity, diffusing capacity for carbon monoxide using the single-breath method, and alveolar volume using single-breath neon wash-in were measured. RESULTS: Our study population was composed of 16 men and 6 women with a median age of 45 years (range, 28-49 years). Median survival was 2.1 years, with 1- and 2-year survival rates of 68% and 53%, respectively. Of the 22 patients, 2 were current smokers, 14 were former smokers, and 6 had never smoked. Three patients had familial pulmonary fibrosis, 21 had bibasilar inspiratory crackles, and 10 had digital clubbing. Median total lung capacity was 56.2%, vital capacity was 51.0%, diffusing capacity was 45.5%, and alveolar volume was 65.0%. CONCLUSION: Although previous studies have suggested that younger age is a favorable prognostic factor in patients with IPF, we found that younger patients have the same poor prognosis as do older patients with this disorder. We observed no distinguishing differences in the clinical, radiological, and histopathologic features compared with those in older patients in whom the disorder is more common. Lung transplantation should be considered early in the treatment of younger patients with IPF.

UR - http://www.scopus.com/inward/record.url?scp=11344283878&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=11344283878&partnerID=8YFLogxK

M3 - Article

C2 - 15667027

AN - SCOPUS:11344283878

VL - 80

SP - 37

EP - 40

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 1

ER -